|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: PFIZER INC, 8-K, 2000-08-28 |
Next: PFIZER INC, 8-K, EX-99.2, 2000-08-28 |
Exhibit 99.1
|
PFIZER INC |
||||||||||||
|
SEGMENT/PRODUCT REVENUES |
||||||||||||
|
FIRST QUARTER 1999 |
||||||||||||
|
(millions of dollars) |
||||||||||||
|
***********QUARTER-TO-DATE************ |
||||||||||||
|
WORLDWIDE |
U.S. |
INTERNATIONAL |
||||||||||
|
1999 |
1998 |
% |
1999 |
1998 |
% |
1999 |
1998 |
% |
||||
|
TOTAL REVENUES |
6,580 |
5,176 |
27 |
3,987 |
2,999 |
33 |
2,593 |
2,177 |
19 |
|||
|
PHARMACEUTICALS |
5,239 |
3,947 |
33 |
3,330 |
2,410 |
38 |
1,909 |
1,537 |
24 |
|||
|
TOTAL HUMAN PHARMACEUTICALS |
4,863 |
3,566 |
36 |
3,174 |
2,254 |
41 |
1,689 |
1,312 |
29 |
|||
|
- CARDIOVASCULAR DISEASES |
1,965 |
1,457 |
35 |
1,128 |
869 |
30 |
837 |
588 |
42 |
|||
|
LIPITOR |
767 |
375 |
104 |
533 |
289 |
84 |
234 |
86 |
173 |
|||
|
NORVASC |
694 |
559 |
24 |
307 |
254 |
21 |
387 |
305 |
26 |
|||
|
CARDURA |
191 |
167 |
15 |
93 |
82 |
14 |
98 |
85 |
16 |
|||
|
ACCUPRIL/ACCURETIC |
116 |
98 |
18 |
52 |
47 |
10 |
64 |
51 |
25 |
|||
|
PROCARDIA XL |
138 |
189 |
(27) |
138 |
189 |
(27) |
0 |
0 |
--- |
|||
|
- INFECTIOUS DISEASES |
1,070 |
858 |
25 |
695 |
517 |
34 |
375 |
341 |
10 |
|||
|
ZITHROMAX |
433 |
301 |
44 |
336 |
227 |
48 |
97 |
74 |
32 |
|||
|
DIFLUCAN |
242 |
226 |
7 |
122 |
116 |
5 |
120 |
110 |
9 |
|||
|
VIRACEPT |
146 |
112 |
30 |
146 |
93 |
57 |
0 |
19 |
(100) |
|||
|
TROVAN |
63 |
41 |
52 |
54 |
41 |
30 |
9 |
0 |
--- |
|||
|
- CENTRAL NERVOUS SYSTEM |
785 |
633 |
24 |
637 |
515 |
24 |
148 |
118 |
26 |
|||
|
ZOLOFT |
517 |
452 |
14 |
425 |
373 |
14 |
92 |
79 |
17 |
|||
|
NEURONTIN |
176 |
96 |
83 |
152 |
81 |
86 |
24 |
15 |
67 |
|||
|
ARICEPT* |
19 |
6 |
194 |
0 |
0 |
--- |
19 |
6 |
194 |
|||
|
- DIABETES |
259 |
208 |
25 |
251 |
199 |
26 |
8 |
9 |
(5) |
|||
|
GLUCOTROL XL |
66 |
57 |
15 |
63 |
55 |
14 |
3 |
2 |
31 |
|||
|
REZULIN |
184 |
138 |
33 |
184 |
138 |
33 |
0 |
0 |
--- |
|||
|
- ALLERGY |
125 |
82 |
52 |
124 |
81 |
52 |
1 |
1 |
(12) |
|||
|
ZYRTEC |
124 |
80 |
54 |
123 |
79 |
55 |
1 |
1 |
(12) |
|||
|
- VIAGRA |
190 |
0 |
--- |
146 |
0 |
--- |
44 |
0 |
--- |
|||
|
- ALLIANCE REVENUE (Aricept |
122 |
10 |
M+ |
121 |
13 |
859 |
1 |
(3) |
--- |
|||
|
- CAPSUGEL |
93 |
94 |
(1) |
39 |
42 |
(7) |
54 |
52 |
4 |
|||
|
- ANIMAL HEALTH |
283 |
287 |
(1) |
117 |
114 |
2 |
166 |
173 |
(4) |
|||
|
CONSUMER PRODUCTS |
1,341 |
1,229 |
9 |
657 |
589 |
11 |
684 |
640 |
7 |
|||
|
- CONSUMER HEALTH CARE |
646 |
569 |
14 |
430 |
368 |
17 |
216 |
201 |
8 |
|||
|
- CONFECTIONERY PRODUCTS |
460 |
444 |
4 |
150 |
150 |
(1) |
310 |
294 |
6 |
|||
|
- SHAVING PRODUCTS |
185 |
167 |
10 |
57 |
51 |
12 |
128 |
116 |
10 |
|||
|
- TETRA |
50 |
49 |
3 |
20 |
20 |
2 |
30 |
29 |
4 |
|||
* - Represents direct sales under license agreement with Eisai Co., Ltd.
M+ - Change greater than one thousand percent.
Restated to reflect the merger with Warner-Lambert Company in June 2000, which was accounted for as a pooling of interests.
Certain amounts and percentages may reflect rounding adjustments.
Certain prior year data have been reclassified to conform to the current year presentation.
|
|